Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 and up

Understanding glucose distribution in severely burned adults

Official title: INDICIA: Evolution of the Initial Distribution Volume of Glucose in the Severe Burned Adults

Run by Centre Hospitalier Régional Metz-Thionville · NCT06469970 · Data updated 2026-11-12

This study is testing how glucose levels change in severely burned adults during their first four days of treatment to help doctors manage their fluids better and improve recovery.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment15 (estimated)
SponsorCentre Hospitalier Régional Metz-Thionville
Academic / other
Locations1 site (Metz)
StatusRecruiting
StartedNovember 28, 2024
Main results expectedMarch 28, 2027
Study endsMarch 28, 2027
Registry record updatedMarch 12, 2026
Trial IDNCT06469970 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 years old with burns covering at least 30% of their body surface area, treated within 8 hours post-injury at the specified burn center.

Probably not a fit

Patients with diabetes requiring insulin or those with contraindications to glucose administration will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, observational, phase II cohort study aims to explore how the initial volume of glucose distribution changes during the first four days of treatment for severely burned patients. It focuses on the challenges of fluid resuscitation in burn victims, who often experience hypovolaemic shock and capillary leak syndrome. By administering a 30% intravenous glucose solution, the study seeks to quantify extracellular fluid volume as a potential marker for fluid overload, which is critical for optimizing patient management and improving outcomes.

Why it matters

Potential benefit: If successful, this study could enhance fluid management strategies for severely burned patients, potentially reducing complications and mortality.

How similar studies have gone: While the approach of using glucose to assess fluid distribution is innovative, similar studies have not been widely reported, indicating this may be a novel exploration.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients over 18 years of age
* Patients hospitalized with burns of at least 30% of body surface area

  * By a thermal mechanism
  * At the CHR Metz-Thionville burn center
  * managed within the 8 hours post-burn
* Patient affiliated to a social security scheme
* Written consent obtained from the patient (or from the trusted person, family or relatives if the patient is unable to sign/express consent) or emergency inclusion if the patient is unable to express consent and neither the trusted support person nor any member of the family or relatives is present at the time of inclusion.

Exclusion Criteria:

* Diabetic patients on insulin
* Patient with a CONTRAINDICATION to GLUCOSE 30% PROAMP, solution for injection
* Patients with pre-hospital cardiac arrest
* extra corporeal circulation patient: Extra Corporeal Membranous Oxygenation (ECMO) or Extra Corporeal Life Support (ECLS) or CRRT (Continuous Renal Replacement Therapy)
* patient without a central venous line or arterial catheter
* Patient moribund or immediately subject to therapeutic limitation
* Impossibility of trans-pulmonary thermodilution monitoring (vascular access difficulties)
* Pregnant, parturient or breast-feeding women
* Patient under guardianship, curatorship or safeguard of justice
* Cognitive impairment or language barrier

Where it's running

  • CHR Metz-Thionville/Hopital de Mercy
    Metz, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.